Lupin Archives - Express Pharma

Lupin’s biosimilar Armlupeg gains U.S.FDA approval

US FDA conclude Lupin’s Nagpur Unit-1 facility inspection with zero observation

Lupin receives EIR from U.S. FDA for Aurangabad facility

Lupin receives EIR from US FDA for its Pithampur unit-3 facility

Lupin to present Phase 1a clinical trial data of STING agonist LNP3693 at ESMO Congress 2025

Lupin receives US FDA approval for Rivaroxaban for oral suspension

Lupin acquires VISUfarma to strengthen ophthalmology business

Lupin gets tentative US FDA nod for Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets

Lupin receives tentative approval from US FDA for Biktarvy tablets

Lupin receives US FDA approval for Lenalidomide capsules